Jennifer A. Woyach, MD, on Using MRD to Treat CLL/SLL

Posted: Monday, November 22, 2021

Jennifer A. Woyach, MD, of The Ohio State University Comprehensive Cancer Center, discusses the logistical challenges for practitioners when it comes to assessing minimal residual disease in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma and determining the best course of treatment.